High expression of flotillin-2 is associated with poor clinical survival in cervical carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 1, 2015, Pages 622-628

  Liu, Yaqiong ^a   Lin, Li ^b   Huang, Zijian ^a   Ji, Bing ^a   Mei, Shanshan ^a   Lin, Ying ^c   Shen, Zhuanxing ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^c People's Hospital of Hunan Province   (China)

Author keywords

Cervical cancer; FLOT2; Prognosis

Indexed keywords

FLOTILLINS; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; AGED; BIOSYNTHESIS; CARCINOMA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX TUMOR;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84923091624     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Huang QT, Zhong M, Gao YF, Huang LP, Huang Q, Wang W, Wang ZJ and Yu YH. Can HPV vaccine have other health benefits more than cancer prevention? A systematic review of association between cervical HPV infection and preterm birth. J Clin Virol 2014; 61: 321-328.
2. Zagouri F, Sergentanis TN, Chrysikos D, Filipits M and Bartsch R. Molecularly targeted therapies in cervical cancer. A systematic review. Gynecol Oncol 2012; 126: 291-303.
3. Banning A, Kurrle N, Meister M and Tikkanen R. Flotillins in receptor tyrosine kinase signaling and cancer. Cells 2014; 3: 129-149.
4. Banning A, Ockenga W, Finger F, Siebrasse P and Tikkanen R. Transcriptional regulation of flotillins by the extracellularly regulated kinases and retinoid X receptor complexes. PLoS One 2012; 7: e45514.
5. Edgar AJ and Polak JM. Flotillin-1: gene structure: cDNA cloning from human lung and the identification of alternative polyadenylation signals. Int J Biochem Cell Biol 2001; 33: 53-64.
6. Hazarika P, McCarty MF, Prieto VG, George S, Babu D, Koul D, Bar-Eli M and Duvic M. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res 2004; 64: 7361-7369.
7. Zhu Z, Wang J, Sun Z, Sun X, Wang Z and Xu H. Flotillin2 expression correlates with HER2 levels and poor prognosis in gastric cancer. PLoS One 2013; 8: e62365.
8. Rickman DS, Millon R, De Reynies A, Thomas E, Wasylyk C, Muller D, Abecassis J and Wasylyk B. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene 2008; 27: 6607-6622.
9. Yan Y, Yang FQ, Zhang HM, Che J and Zheng JH. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression. Tumour Biol 2014; 35: 10479-10486.
10. Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T and Lisanti MP. Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J Biol Chem 1999; 274: 12702-12709.
11. Fernow I, Icking A and Tikkanen R. Reggie-1 and reggie-2 localize in non-caveolar rafts in epithelial cells: cellular localization is not dependent on the expression of caveolin proteins. Eur J Cell Biol 2007; 86: 345-352.
12. Morrow IC, Rea S, Martin S, Prior IA, Prohaska R, Hancock JF, James DE and Parton RG. Flotillin-1/reggie-2 traffics to surface raft domains via a novel golgi-independent pathway. Identification of a novel membrane targeting domain and a role for palmitoylation. J Biol Chem 2002; 277: 48834-48841.
13. Glebov OO, Bright NA and Nichols BJ. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol 2006; 8: 46-54.
14. Pust S, Klokk TI, Musa N, Jenstad M, Risberg B, Erikstein B, Tcatchoff L, Liestol K, Danielsen HE, van Deurs B and Sandvig K. Flotillins as regulators of ErbB2 levels in breast cancer. Oncogene 2013; 32: 3443-3451.
15. Doherty SD, Prieto VG, George S, Hazarika P and Duvic M. High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res 2006; 16: 461-463.
16. Ha H, Kwak HB, Lee SK, Na DS, Rudd CE, Lee ZH and Kim HH. Membrane rafts play a crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function. J Biol Chem 2003; 278: 18573-18580.
17. Neumann-Giesen C, Fernow I, Amaddii M and Tikkanen R. Role of EGF-induced tyrosine phosphorylation of reggie-1/flotillin-2 in cell spreading and signaling to the actin cytoskeleton. J Cell Sci 2007; 120: 395-406.
18. Ludwig A, Otto GP, Riento K, Hams E, Fallon PG and Nichols BJ. Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitment. J Cell Biol 2010; 191: 771-781.
19. Zhang SH, Wang CJ, Shi L, Li XH, Zhou J, Song LB and Liao WT. High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma. PLoS One 2013; 8: e64709.
20. Wang X, Yang Q, Guo L, Li XH, Zhao XH, Song LB and Lin HX. Flotillin-2 is associated with breast cancer progression and poor survival outcomes. J Transl Med 2013; 11: 190.
21. Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y, Wang X, Li J and Song L. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a. Clin Cancer Res 2011; 17: 3089-3099.
22. Song L, Gong H, Lin C, Wang C, Liu L, Wu J, Li M and Li J. Flotillin-1 promotes tumor necrosis factor-alpha receptor signaling and activation of NF-kappaB in esophageal squamous cell carcinoma cells. Gastroenterology 2012; 143: 995-1005, e1012.